702 filings
Page 25 of 36
8-K/A
modj7wxhi4
21 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
n1h7l u0z
21 Jun 11
Departure of Directors or Certain Officers
12:00am
S-8
fbcbml
8 Jun 11
Registration of securities for employees
12:00am
8-K
jum356aqzc7lt5l7lji
6 Jun 11
New Clinical Data Analysis of AMPYRA® (dalfampridine) Shows Improvement of
12:00am
CORRESP
1cijo1wqwxm
26 May 11
Correspondence with SEC
12:00am
8-K
zorq1 s5oqyda8
20 May 11
Acorda Therapeutics Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA® in Europe
12:00am
UPLOAD
6cgvvrsy oz
13 May 11
Letter from SEC
12:00am
ARS
ibh99qh lljc5cnxjq7
9 May 11
Annual report to shareholders
12:00am
8-K
xxlz2hic09fheqe2q1
5 May 11
Results of Operations and Financial Condition
12:00am
8-K
ahmlmop5wdg6qe
21 Apr 11
Acorda Therapeutics Announces Changes to Board of Directors
12:00am
8-K
jg1m8
19 Apr 11
Other Events
12:00am
8-K
po7l peuhhku9b31
11 Apr 11
Other Events
12:00am
CORRESP
w1y8pfwn1ft6l8xx
23 Mar 11
Correspondence with SEC
12:00am
UPLOAD
ekk5h0
10 Mar 11
Letter from SEC
12:00am
8-K
5xrepyeb
7 Mar 11
Other Events
12:00am
8-K/A
z96h3
18 Feb 11
Results of Operations and Financial Condition
12:00am
8-K
h99m y0zix8
17 Feb 11
Results of Operations and Financial Condition
12:00am